Viome Life Sciences introduced it had raised $67 million in Collection C funding led by Daring Capital Group.
The increase, which included participation from current buyers Khosla Ventures, West River Group, Glico, Ocgrow Ventures and Doctor Companions, brings the corporate’s increase to greater than $150 million.
Viome presents intestine microbiome checks for customers and supplies vitamin suggestions primarily based on outcomes. It additionally acquired FDA Breakthrough Gadget Designation final yr for its mRNA evaluation know-how and synthetic intelligence platform that goals to detect early indicators of oral and throat cancers. The Breakthrough Units program is not a advertising and marketing authorization from the FDA, although the purpose is to hurry the event and evaluation of merchandise to deal with or diagnose life-threatening or debilitating illnesses or situations.
Viome plans to make use of the capital to launch a brand new line of checks centered on the oral microbiome. The corporate raised $54 million final yr and expanded its partnership with GlaxoSmithKline to analysis and probably develop interventions for some cancers and autoimmune illnesses.
Genomic testing firm Variantyx introduced in $20 million in debt financing from Kreos Capital.
The startup presents genomic testing and analytics for uncommon genetic problems, reproductive well being and precision oncology. Earlier this yr, Variantyx introduced a $41.5 million C-2 funding spherical.
“Variantyx has constructed a singular and superior platform for precision medication and its skill to course of the entire genome units it aside within the genomic diagnostics market. Our funds, which improve the corporate’s already robust capital place, will permit it to considerably scale up its industrial efforts,” Aris Constantinides, common associate of Kreos Capital, mentioned in a press release.
In-person and digital psychological well being supplier Aware Care scooped up $7 million in a Collection B spherical led by Sopris Capital.
Others taking part within the increase embody the College of Chicago, the Caruso Basis and the Venkon Group. The startup introduced a $2.7 million Collection A a yr in the past, and a $1.5 million family and friends spherical in 2020.
Aware Care will use the Collection B to develop in areas together with the Midwest and Southeast, launch particular person remedy and dependancy therapy applications, and proceed to develop its know-how.
Rhino Well being, which presents a platform that permits researchers and healthcare AI builders to entry and collaborate round numerous datasets, introduced a $6.7 million extension to its seed spherical final week.
Fusion Fund and LionBird Ventures co-led the spherical with participation from Qiming Enterprise Companions, Maccabi Well being Companies and Arkin Holdings.
The corporate introduced it had scooped up $5 million in February 2021. Rhino’s whole funding pot now involves $11.7 million.
“The Rhino Well being Platform solves an actual want within the healthcare AI trade — entry to bigger, extra numerous and evolving datasets. The progress we have made with our companions thus far offers us nice confidence that distributed computing and federated studying are a sport changer for healthcare,” cofounder and CTO Yuval Baror mentioned in a press release. “Permitting healthcare organizations to maintain knowledge inside their knowledge programs, whereas offering builders a distributed computing platform to securely work with this knowledge, will speed up the following wave of healthcare innovation.”
Kyros, a platform that connects sufferers with substance use dysfunction with suppliers and different sources, raised one other $2.4 million in seed funding led by Rally Ventures, with participation from strategic angel buyers.
The startup launched in Minnesota earlier this yr, and introduced a $4.4 million seed increase in July. Kyros plans to make use of the funding to proceed creating its platform, develop into new markets and rent staffers.
